MDCXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCXW
Medicus Pharma Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.65−0.60 (-18.31%)
Close on Oct 19, 2026
- Market cap
- $146.17M
- P/E (TTM)
- –
- Dividend yield
- –